Company
United StatesPublic company, NASDAQ: SNDXSyndax Pharmaceuticals Inc. (NASDAQ: SNDX), New York, NY – FDA Inspections
Inspection records and compliance data for Syndax Pharmaceuticals Inc. in New York, New York. 1 FDA inspection on record, last inspected August 22, 2024. Publicly traded as NASDAQ: SNDX.
Company Profile
This profile covers Syndax Pharmaceuticals Inc. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 22, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 22, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1248594 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Syndax Pharmaceuticals Inc.
Stock ticker
SNDX
Exchange
NASDAQ
Share price
$9.37
Market cap
$842.8M
Price as of
November 6, 2026
FEI Number
3030420888
Address
730 3rd Ave Fl 9, New York, New York 10017, United States
Country
United States
ID: d14fa1f9-f986-4dbb-900c-06fddb9bc830